Pacific Edge Limited (PFGTF)
USD 0.06
(0.0%)
USD 0.06
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -29.53 Million NZD | -9.53% |
| 2023 | -26.96 Million NZD | -23.0% |
| 2022 | -13.71 Million NZD | -37.71% |
| 2021 | -9.96 Million NZD | 11.03% |
| 2020 | -11.19 Million NZD | 37.51% |
| 2019 | -17.91 Million USD | 8.79% |
| 2018 | -19.64 Million USD | 13.03% |
| 2017 | -22.58 Million USD | -107.51% |
| 2016 | -10.88 Million USD | -16.43% |
| 2015 | -9.34 Million NZD | -8.26% |
| 2014 | -8.63 Million NZD | -49.28% |
| 2013 | -5.78 Million NZD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -4.68 Million USD | 53.48% |
| 2024 Q2 | -4.57 Million USD | -100.0% |
| 2024 FY | -29.53 Million NZD | -75.05% |
| 2024 Q4 | -4.27 Million USD | 0.0% |
| 2024 Q3 | -4.51 Million USD | 53.18% |
| 2023 FY | -16.87 Million NZD | -23.0% |
| 2023 Q4 | -5.12 Million USD | 1.5% |
| 2023 Q3 | -5.2 Million USD | -76.04% |
| 2023 Q2 | -2.95 Million USD | 0.0% |
| 2022 FY | -13.71 Million NZD | -37.71% |
| 2022 Q2 | -6.19 Million USD | 0.0% |
| 2022 Q4 | -7.48 Million USD | 0.0% |
| 2021 Q2 | -4.68 Million USD | 0.0% |
| 2021 FY | -9.96 Million NZD | 11.03% |
| 2021 Q4 | -4.99 Million USD | 0.0% |
| 2020 Q2 | -5.88 Million USD | 0.0% |
| 2020 Q4 | -5.63 Million USD | 0.0% |
| 2020 FY | -11.19 Million NZD | 37.51% |
| 2019 FY | -17.91 Million USD | 8.79% |
| 2018 FY | -19.64 Million USD | 13.03% |
| 2017 FY | -22.58 Million USD | -107.51% |
| 2016 FY | -10.88 Million USD | -16.43% |
| 2015 FY | -9.34 Million NZD | -8.26% |
| 2014 FY | -8.63 Million NZD | -49.28% |
| 2013 FY | -5.78 Million NZD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| American Bio Medica Corporation | -1.41 Million USD | -1994.681% |
| Arrayit Corporation | -3.31 Million USD | -790.791% |
| Atlantic International Corp. | -5.62 Million USD | -424.825% |
| Biocept, Inc. | -32.08 Million USD | 7.953% |
| Bioqual, Inc. | 483.48 Thousand USD | 6208.823% |
| CardioGenics Holdings Inc | -1.91 Million USD | -1441.232% |
| DermTech, Inc. | -100.88 Million USD | 70.725% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.02 Billion USD | 101.459% |
| HTG Molecular Diagnostics, Inc. | -21.59 Million USD | -36.771% |
| iMD Companies, Inc. | -200.63 Thousand USD | -14620.688% |
| IDenta Corp. | 14.64 Thousand USD | 201786.698% |
| Interpace Biosciences, Inc. | 802 Thousand USD | 3782.668% |
| Integrative Health Technologies, Inc. | 38.68 Thousand USD | 76439.528% |
| InVitro International | 1553.00 USD | 1901902.962% |
| Lumos Diagnostics Holdings Limited | -8.59 Million USD | -243.75% |
| Many Bright Ideas Technologies Inc. | -58.11 Thousand USD | -50724.27% |
| Medical Imaging Corp. | -3.02 Million USD | -877.002% |
| NovelStem International Corp. | -4.18 Million USD | -605.347% |
| Optigenex Inc. | -2.89 Million USD | -919.236% |
| PharmChem, Inc. | 845.1 Thousand USD | 3594.844% |
| Proteome Sciences plc | -2.44 Million USD | -1108.964% |
| Response Genetics, Inc | -20.18 Million USD | -46.329% |
| Rennova Health, Inc. | -3.29 Million USD | -796.888% |
| RushNet, Inc. | -607.02 Thousand USD | -4765.509% |
| ScreenPro Security Inc. | -2.24 Million USD | -1213.386% |
| Stella Diagnostics Inc. | -5.7 Million USD | -417.484% |
| StageZero Life Sciences Ltd. | -11.41 Million USD | -158.73% |
| Todos Medical Ltd. | -24.99 Million USD | -18.168% |